Targeting ATR in vivo using the novel inhibitor VE-822 results in selective sensitization of pancreatic tumors to radiation
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Targeting ATR in vivo using the novel inhibitor VE-822 results in selective sensitization of pancreatic tumors to radiation
Authors
Keywords
-
Journal
Cell Death & Disease
Volume 3, Issue 12, Pages e441-e441
Publisher
Springer Nature
Online
2012-12-06
DOI
10.1038/cddis.2012.181
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Targeting radiation-resistant hypoxic tumour cells through ATR inhibition
- (2012) I M Pires et al. BRITISH JOURNAL OF CANCER
- The novel ATR inhibitor VE-821 increases sensitivity of pancreatic cancer cells to radiation and chemotherapy
- (2012) Remko Prevo et al. CANCER BIOLOGY & THERAPY
- Neoadjuvant Therapy of Pancreatic Cancer: The Emerging Paradigm?
- (2012) K.-H. Lim et al. ONCOLOGIST
- NVP-BEZ235 and NVP-BGT226, dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitors, enhance tumor and endothelial cell radiosensitivity
- (2012) Emmanouil Fokas et al. Radiation Oncology
- Identification and evaluation of a potent novel ATR inhibitor, NU6027, in breast and ovarian cancer cell lines
- (2011) A Peasland et al. BRITISH JOURNAL OF CANCER
- Systematic review of immunohistochemical biomarkers to identify prognostic subgroups of patients with pancreatic cancer
- (2011) D. Ansari et al. BRITISH JOURNAL OF SURGERY
- Dual Inhibition of the PI3K/mTOR Pathway Increases Tumor Radiosensitivity by Normalizing Tumor Vasculature
- (2011) E. Fokas et al. CANCER RESEARCH
- Imaging DNA Damage In Vivo Using H2AX-Targeted Immunoconjugates
- (2011) B. Cornelissen et al. CANCER RESEARCH
- Oncogenic stress sensitizes murine cancers to hypomorphic suppression of ATR
- (2011) David W. Schoppy et al. JOURNAL OF CLINICAL INVESTIGATION
- Discovery of Potent and Selective Inhibitors of Ataxia Telangiectasia Mutated and Rad3 Related (ATR) Protein Kinase as Potential Anticancer Agents
- (2011) Jean-Damien Charrier et al. JOURNAL OF MEDICINAL CHEMISTRY
- Selective killing of ATM- or p53-deficient cancer cells through inhibition of ATR
- (2011) Philip M Reaper et al. Nature Chemical Biology
- The importance of local control in pancreatic cancer
- (2011) Edgar Ben-Josef et al. Nature Reviews Clinical Oncology
- Harnessing synthetic lethal interactions in anticancer drug discovery
- (2011) Denise A. Chan et al. NATURE REVIEWS DRUG DISCOVERY
- Exploiting oncogene-induced replicative stress for the selective killing of Myc-driven tumors
- (2011) Matilde Murga et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- A cell-based screen identifies ATR inhibitors with synthetic lethal properties for cancer-associated mutations
- (2011) Luis I Toledo et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- ATR mediates cisplatin resistance in a p53 genotype-specific manner
- (2011) N Sangster-Guity et al. ONCOGENE
- Guidelines for the welfare and use of animals in cancer research
- (2010) P Workman et al. BRITISH JOURNAL OF CANCER
- Combining ATR Suppression with Oncogenic Ras Synergistically Increases Genomic Instability, Causing Synthetic Lethality or Tumorigenesis in a Dosage-Dependent Manner
- (2010) O. Gilad et al. CANCER RESEARCH
- Radiosensitization by Chir-124, a selective Chk1 inhibitor: Effects of p53 and cell cycle checkpoints
- (2010) Yungan Tao et al. CELL CYCLE
- Advanced pancreatic carcinoma: current treatment and future challenges
- (2010) Anastasios Stathis et al. Nature Reviews Clinical Oncology
- Genomic instability — an evolving hallmark of cancer
- (2010) Simona Negrini et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Pancreatic Cancer
- (2010) Manuel Hidalgo NEW ENGLAND JOURNAL OF MEDICINE
- The role of radiotherapy in multimodal treatment of pancreatic carcinoma
- (2010) Thomas B Brunner et al. Radiation Oncology
- Single Nucleotide Polymorphisms of Gemcitabine Metabolic Genes and Pancreatic Cancer Survival and Drug Toxicity
- (2009) T. Okazaki et al. CLINICAL CANCER RESEARCH
- The DNA-damage response in human biology and disease
- (2009) Stephen P. Jackson et al. NATURE
- Tissue regenerative delays and synthetic lethality in adult mice after combined deletion of Atr and Trp53
- (2009) Yaroslava Ruzankina et al. NATURE GENETICS
- A mouse model of ATR-Seckel shows embryonic replicative stress and accelerated aging
- (2009) Matilde Murga et al. NATURE GENETICS
- Epidemiology of pancreatic cancer: an overview
- (2009) Sara Raimondi et al. Nature Reviews Gastroenterology & Hepatology
- Single-Strand Annealing, Conservative Homologous Recombination, Nonhomologous DNA End Joining, and the Cell Cycle-Dependent Repair of DNA Double-Strand Breaks Induced by Sparsely or Densely Ionizing Radiation
- (2009) Marlis Frankenberg-Schwager et al. RADIATION RESEARCH
- ATR and Chk1 Suppress a Caspase-3–Dependent Apoptotic Response Following DNA Replication Stress
- (2009) Katie Myers et al. PLoS Genetics
- Class I PI3 Kinase Inhibition by the Pyridinylfuranopyrimidine Inhibitor PI-103 Enhances Tumor Radiosensitivity
- (2008) R. Prevo et al. CANCER RESEARCH
- Chk1 Suppresses a Caspase-2 Apoptotic Response to DNA Damage that Bypasses p53, Bcl-2, and Caspase-3
- (2008) Samuel Sidi et al. CELL
- Core Signaling Pathways in Human Pancreatic Cancers Revealed by Global Genomic Analyses
- (2008) S. Jones et al. SCIENCE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started